Generics regulatory convergence project extended to more drugs

The European Medicines Agency is to begin sharing its assessment reports on generic medicines with selected non-EU regulatory agencies as part of a drive to improve the efficiency of review processes and make it possible to synchronize marketing authorizations across different jurisdictions1,2.